In its presentation at JPMorgan's Healthcare Conference in San Francisco, Illumina (ILMN -0.8%)...


In its presentation at JPMorgan's Healthcare Conference in San Francisco, Illumina (ILMN -0.8%) says that preliminary Q4 revenue was $309M, beating Street expectations of $302M. EPS is tracking to the midpoint of range guidance. Street EPS estimates are for $0.42. (Presentation Webcast)

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs